• Mashup Score: 0

    Philadelphia-negative myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF), are hematologic malignancies characterized by the abnormal proliferation of blood cells in the bone marrow. MPNs cause significant morbidity in the form of burdensome symptoms, potentially fatal cardiovascular complications, progression to…

    Tweet Tweets with this article
    • There are more and better options to treat #MPNs than ever, and many potential new treatments in late-stage clinical trials. Read a treatment landscape summary HERE: https://t.co/e8FL9zWPOl #BCAM #ThisIsBloodCancer @RaajitRampal @GhaithAbuZeinah @MSKCancerCenter @WCMLeukemia https://t.co/Z08JCe9V26

  • Mashup Score: 0

    MPN Research Foundation Awards Additional $1.8 Million for Blood Cancer Research into Myeloproliferative Neoplasms Dec. 14, 2022 (Chicago) − MPN Research Foundation (MPNRF) announces its 2022 Thrive Initiative recipients for projects that fill research funding gaps, some of which surfaced due to the pandemic. This $1.8 million in awards is in addition to currently funded…

    Tweet Tweets with this article
    • Congrats to all the recipients of @myMPNRF funding & kudos to #MPNresearchFoundation for continuing to fund MPN research #mpnsm Thrive Initiative Press Release https://t.co/pudP40vF2p #MPNresearchFoundation

  • Mashup Score: 1

    With MPN research rapidly advancing, participation in a clinical trial can offer people living with ET, PV and MF access to new and better treatments. At the same time, it can help bring new approved treatment options to more patients at various stages of their MPN.Finding an MPN clinical trial that matches your diagnosis and…

    Tweet Tweets with this article
    • RT @MPN_RF: Now easily match your #MPNs diagnosis/history w/current #clinicaltrials. Click link https://t.co/oKBgNmmu24 to MPN Research Fou…

  • Mashup Score: 1

    With MPN research rapidly advancing, participation in a clinical trial can offer people living with ET, PV and MF access to new and better treatments. At the same time, it can help bring new approved treatment options to more patients at various stages of their MPN.Finding an MPN clinical trial that matches your diagnosis and…

    Tweet Tweets with this article
    • RT @MPN_RF: Looking for a clinical trial? We now have an easy to use MPN Research Foundation clinical trial finder https://t.co/Yh38znhxHH…

  • Mashup Score: 1

    How MPNs Affect Women Myeloproliferative neoplasms (MPNs) can affect both men and women. However, there are some important differences in the way MPNs impacts each sex as well as specific issues that affect women who have been diagnosed with an MPN.Essential thrombocythemia (ET) tends to be more prevalent in women, while polycythemia vera (PV) and primary myelofibrosis…

    Tweet Tweets with this article
    • RT @CanadianMpn: On International Women's Day, a look at the unique considerations for women MPN patients: https://t.co/v8DM23PbRI #interna…

  • Mashup Score: 1

    Funding groundbreaking research. Changing lives. Helping people with an MPN live a better quality of life as we work toward answers to prevention, progression and a cure for polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF) – blood cancers collectively known as myeloproliferative…

    Tweet Tweets with this article
    • RT @briheller: Donate to help prevent/treat/cure MPN Blood Cancers (myeloproliferative neoplasms) https://t.co/nRnysS0gc1 My MIL (more…